Allermi

San Francisco, United States

Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.

Apr 2024

Series A

Top Investors

Shane NemanLucas Venture GroupNelstone Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Allermi's investors?

Allermi's investors include Shane Neman, Lucas Venture Group, Nelstone Ventures.

Where is Allermi headquartered?

Allermi is headquartered in San Francisco, United States.

What does Allermi do?

Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.

What stage is Allermi at?

Allermi is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2024.

MLA

"Allermi — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/allermi. Accessed June 17, 2026.

APA

VCBacked. (2024). Allermi — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/allermi

Wikipedia (cite web)

{{cite web |title=Allermi — Funding & Investors |url=https://www.vcbacked.co/company/allermi |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2024.